These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25559655)

  • 41. [Glimepiride in daily practice].
    Jasik M
    Przegl Lek; 2003; 60(6):409-12. PubMed ID: 14974179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The second-generation sulfonylureas: change or progress?
    Kreisberg RA
    Ann Intern Med; 1985 Jan; 102(1):125-6. PubMed ID: 3966729
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.
    Katakami N; Kaneto H; Matsuhisa M; Shimomura I; Yamasaki Y
    Diabetes Res Clin Pract; 2011 Apr; 92(1):e20-2. PubMed ID: 21257219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
    Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
    Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
    [No Abstract]   [Full Text] [Related]  

  • 45. Are sulfonylureas passé?
    Green JB; Feinglos MN
    Curr Diab Rep; 2006 Nov; 6(5):373-7. PubMed ID: 17076998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Oral antidiabetic agents: what are the choices?].
    Crausaz FM
    Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244
    [No Abstract]   [Full Text] [Related]  

  • 47. Glimepiride in type 2 diabetes mellitus Thai patients.
    Deerochanawong C; Chandraprasert S; Suthijumroon A; Vichayanrat A; Himathongkam T; Nitiyanant W; Benjasuratawong Y; Suwanwalaikorn S; Sarinnapakorn V; Vongterapak S
    J Med Assoc Thai; 2001 Sep; 84(9):1221-8. PubMed ID: 11800292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multicenter study with gliquidone in type 2 diabetes mellitus].
    Kreze A; Vozár J; Rázus P; Lacko A; Málek Z; Putz Z
    Vnitr Lek; 1991; 37(9-10):761-7. PubMed ID: 1771808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
    Tirkkonen T; Heikkilä P; Huupponen R; Laine K
    J Intern Med; 2010 Oct; 268(4):359-66. PubMed ID: 20698928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inappropriate antidiuretic hormone secretion syndrome associated with ramipril treatment].
    Arroyo Domingo E; Soriano Bel A; Yuste Vila D; Andreu Giménez L
    Farm Hosp; 2010; 34(3):154-5. PubMed ID: 20471574
    [No Abstract]   [Full Text] [Related]  

  • 51. The diagnostic value of determining the hydroxy metabolite of glimepiride (M1) in blood serum in cases of severe hypoglycaemia associated with glimepiride therapy.
    Holstein A; Plaschke A; Ptak M; Egberts EH; Tenberken O; Maurer HH
    Diabetes Obes Metab; 2004 Sep; 6(5):391-3. PubMed ID: 15287933
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the effectiveness and tolerability of gliquidone in the treatment of diabetes mellitus type II].
    Iori I; Bosi E; Manicardi E; Del Din G; Dini FL; Portioli I
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):277-83. PubMed ID: 2640049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulphonylurea dose-response relationships: relation to clinical practice.
    Lindblad U; Melander A
    Diabetes Obes Metab; 2000 Jan; 2(1):25-31. PubMed ID: 11220350
    [No Abstract]   [Full Text] [Related]  

  • 54. Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes.
    Barry HC
    Am Fam Physician; 2016 Sep; 94(5):386. PubMed ID: 27583428
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of glimepiride for the treatment of diabetes occurring during glucocorticoid therapy.
    Kasayama S; Tanaka T; Hashimoto K; Koga M; Kawase I
    Diabetes Care; 2002 Dec; 25(12):2359-60. PubMed ID: 12453992
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of glimepiride on the pharmacokinetics of teneligliptin in healthy Korean subjects.
    Park JW; Kim KA; Choi YJ; Yoon SH; Park JY
    J Clin Pharm Ther; 2019 Oct; 44(5):720-725. PubMed ID: 31094010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus].
    Degtiareva II; Lodianaia EV; Opanasiuk ND; Palladina OL
    Lik Sprava; 1995; (7-8):84-7. PubMed ID: 8846383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination.
    Nersesyan AK
    Food Chem Toxicol; 2011 Sep; 49(9):2470. PubMed ID: 21683753
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
    Sehra D; Sehra S
    Recent Adv Cardiovasc Drug Discov; 2015; 10(1):4-9. PubMed ID: 26767545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulphonylureas, magnesium and cardiac K+ ATP channels.
    Matz R
    Diabetologia; 2000 Aug; 43(8):1080-1. PubMed ID: 10990091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.